+17 C°
Traffic jam:   0

European market grew up by AstraZeneca's vaccine approval

31 December 2021
2 min.
European market grew up by AstraZeneca's vaccine approval

Vaccine approval has impacted on stock rally

The European stock market rallied on Wednesday as Britain approved a COVID-19 vaccine developed jointly by AstraZeneca (LON:AZN) and Oxford University, while bets on additional US financial assistance and a massive vaccination effort raised hopes for a strong global economic recovery next year, Reuters wrote.

The pan-European STOXX 600 index rose 0.2 per cent to a 10-month high in the previous session.

AstraZeneca shares were up 1.3% after initially rising 3.3% in anticipation of the news. The drug maker said the vaccine has been approved for emergency use and involves two doses. The UK is battling a new, much more infectious variant of the virus.

It was an added boost to British markets after the UK and EU struck a Brexit trade deal last week, preventing a chaotic exit from the bloc at the end of the year. The British parliament is expected to debate and pass the deal later on Wednesday.

However, most of the region's indices traded sluggishly due to low volumes during the shortened week due to the holidays. Germany's DAX index was unchanged, while indices in France and Spain fell 0.1%.

Unicaja shares rose more than 2%, while Liberbank (MC:LBK) fell 3.6% after both banks announced an all-stock deal that would create Spain's fifth-largest bank with about 110 billion euros ($134.71 billion) in assets. Shares in HSBC (BA:HSBC), Lloyds Banking Group (NYSE:LYG) and Barclays (NYSE:BCS) were up nearly 2%, with the UK blue-chip FTSE 100 index up 0.3%.

The broader banking index is up 0.8%, but is one of the sectors with the worst performance this year along with energy, as a rise in problem loans due to the impact of the pandemic and record low interest rates has reduced the sector's appeal.

Travel and leisure sector papers rose 0.9% on average as the introduction of the COVID-19 vaccine on the continent reduced infection rates.

Meanwhile, Wall Street indexes hit record highs this week on hopes that US lawmakers will approve a big fiscal stimulus package despite delays.

Companies7 in the news

2 place
3 place
4 place
5 place
7 place


Rating companies
66 Mention
65 Mention
61 Mention
54 Mention
Dow Jones
49 Mention
49 Mention
35 Mention


News from GlobalNY.biz is the freshest and most relevant information about high-profile events in the region. The task of the resource's news feed is to convey to readers with maximum accuracy and objectivity information about important events in business, politics, economy, healthcare, culture and other spheres of life in New York.
GlobalNY.biz news is a coverage of economic processes taking place in New York, the latest news of public life, incidents and an overview of political events. New York news is information about the activities of small and medium-sized businesses, the work of housing and communal services and utilities, the implementation of significant projects.
The site's journalists describe not only the life of the region, but also talk about the current state of the US economy. Everything you need to know about innovations in the field of industry and agriculture, economy and power is collected in the "News" section at GlobalNY.biz.
New York news quickly informs the reader, shows the real picture and opens up hot topics. Communication with government structures and business enables us to provide our readers with reliable, information-rich material. The main page of the portal contains the key news of New York!
Alena Potapova

Development Director